Skip NavigationSkip to Content

Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load

  1. Author:
    Miley, W. J.
    Suryanarayana, K.
    Manns, A.
    Kubota, R.
    Jacobson, S.
    Lifson, J. D.
    Waters, D.
  2. Author Address

    Waters D NCI, Frederick Canc Res & Dev Ctr, Human Retrovirus Sect, SAIC Frederick Frederick, MD 21702 USA NCI, Frederick Canc Res & Dev Ctr, Human Retrovirus Sect, SAIC Frederick Frederick, MD 21702 USA NCI, Frederick Canc Res & Dev Ctr, SAIC Frederick, Lab Retroviral Pathogenesis,AIDS Vaccine Program Frederick, MD 21702 USA NCI, Viral Epidemiol Branch, NIH Rockville, MD 20852 USA NINDS, NIH Bethesda, MD 20892 USA
    1. Year: 2000
  1. Journal: Aids Research and Human Retroviruses
    1. 16
    2. 7
    3. Pages: 665-675
  2. Type of Article: Article
  1. Abstract:

    We have developed a quantitative real-time PCR assay for HTLV-I DNA, This assay approach uses real-time monitoring of fluorescent signal generation as a consequence of Tag-mediated amplification of specific target sequences to allow real-time kinetic analysis of amplicon production. This kinetic approach yields excellent sensitivity and an extremely broad linear dynamic range, and ensures that quantitation is based on analysis during the exponential phase of amplification, regardless of the input template copy number. The HTLV-I DNA assay has a nominal threshold sensitivity of 10 copy Eq/reaction, although single-copy plasmid template can be detected at frequencies consistent with statistical prediction. The linear dynamic range is in excess of 5 logs, Interassay reproducibility averages 14% (coefficient of variation) for control templates over a range of 10(1) to 10(6) copy Eq/reaction and 25%, based on studies of extraction and analysis of replicate aliquots of PBMC specimens from HTLV-I-infected subjects. The primer/probe combination targets tax sequences conserved across described HTLV-I and HTLV-II isolates. Parallel quantitation in the same samples of an endogenous sequence present at a known copy number per cell allows normalization of results for potential variation in DNA recovery. Availability of this assay should facilitate studies of basic pathogenesis and clinical evaluation of HTLV-I and HTLV-II infection, as well as assessment of therapeutic approaches. [References: 53]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel